What to Expect If You Refuse Cancer Treatment

Refusing cancer treatment generally means the disease will follow its natural course, which for most cancers means continued growth, spread to other parts of the body, worsening symptoms, and a significantly shorter life. How quickly that happens and how severe it gets depends on the type and stage of cancer, your age, and your overall health. Some slow-growing cancers may take years to cause serious problems, while aggressive ones can become life-threatening within months. The decision is deeply personal, and understanding the likely trajectory can help you or someone you love make it with open eyes.

How Survival Changes Without Standard Treatment

The clearest evidence on what happens without conventional treatment comes from studies comparing patients who accept standard care with those who choose alternatives or refuse altogether. In breast cancer, which has some of the most detailed data, patients who used alternative medicine instead of conventional therapy had a five-year survival rate of about 54%, compared with 82% for those who received standard treatment. The risk of death was roughly four times higher in the alternative-medicine group after adjusting for factors like stage and age, and this held true across early-stage, mid-stage, and advanced disease.¹

Those numbers represent what happens when people replace standard treatment entirely. The gap is even more striking in early-stage disease, where conventional treatment is most effective. Patients with stage I or II breast cancer who chose alternatives had about 67% five-year survival versus 91% for those who accepted standard care.¹ That gap represents real lives and real years lost to cancers that were likely curable.

Not all cancers behave the same way, of course. A large analysis of over four million cancer patients found that 20-year survival rates vary enormously depending on the type: thyroid cancer has a 20-year relative survival of about 95%, while other cancers are far more lethal even with treatment.² This means refusing treatment for a slow-growing thyroid tumor carries very different stakes than refusing it for an aggressive lung or pancreatic cancer. The biology of the tumor matters as much as whether you treat it.

What Actually Happens in Your Body

When cancer goes untreated, it does not simply sit there. Most tumors continue to grow and eventually invade nearby structures. One study of untreated hormone-receptor-positive breast cancers found that the median tumor volume doubling time was about 385 days, meaning the mass roughly doubled in size every year or so. Some tumors were much faster, doubling in as little as 23 days, while others took years.³ Higher-grade tumors and larger tumors at diagnosis grew faster. This is one relatively favorable subtype of breast cancer; more aggressive cancers can grow much more rapidly.

As the cancer grows and spreads, symptoms accumulate. Research on advanced cancer patients consistently shows that people with untreated or progressing cancers are dealing with many symptoms at once, not just one or two. Pain, fatigue, and loss of appetite are among the ten most common symptoms across virtually every type of cancer. When symptoms like pain, weakness, anxiety, shortness of breath, and constipation are present, the majority of patients rate them as moderate to severe.⁴ The specific symptom pattern depends on where the cancer is and where it spreads, but the overall picture is one of mounting discomfort and declining function.

Beyond gradual worsening, untreated cancers can cause sudden medical emergencies. Tumors can press on the spinal cord, causing paralysis. They can erode into blood vessels, causing hemorrhage. They can block the bowel, obstruct airways, or cause dangerous swings in blood chemistry. These emergencies arise in both treated and untreated patients, but without treatment to slow or shrink the cancer, they become more likely over time.⁵

Why People Refuse Treatment

The reasons are more varied and more human than many doctors expect. Analysis of a large U.S. health survey found that people with cancers of internal organs refused treatment at roughly twice the rate of those with breast cancer, and that education level played a significant role: individuals without a high school diploma were about twice as likely to refuse treatment as those with more education. Gender, interestingly, did not show a statistically significant link to refusal.⁶

Trust in the medical system is another major factor. A study of lung cancer patients who declined recommended surgery found that those who refused were more likely to be Black and to have lower incomes. Among those who refused, a majority reported not trusting their physician, and nearly half described inadequate communication. Qualitative interviews revealed recurring themes: a lack of understanding of the disease and prior bad experiences with the healthcare system that shaped their willingness to accept treatment now.⁷

Research into the decision-making process also shows that patients who refuse treatment are often not basing the choice on the medical information presented to them. Instead, they draw heavily on personal experiences or the experiences of people close to them, such as watching a friend or family member suffer through chemotherapy. The decision becomes about life values and past trauma more than about statistics.⁸ Older age can also play a role. In one study of oral cancer patients, about 31% refused recommended follow-up therapy after surgery, and those who refused were significantly more likely to be older.⁹

The Alternative Medicine Question

Many people who refuse conventional cancer treatment are not choosing to do nothing. They are choosing something else: herbal remedies, special diets, energy healing, homeopathy, high-dose vitamins, or other alternative approaches. This is an important distinction because the outcomes are measurable, and the evidence is not encouraging.

A study using a national cancer database found that patients who used complementary medicine were significantly more likely to refuse surgery, chemotherapy, radiotherapy, and hormone therapy compared to patients who did not use complementary medicine. The complementary medicine users had lower five-year survival, roughly 82% compared with about 87% for those who stuck with conventional treatment alone. The key finding was that complementary medicine use itself was not the direct cause of worse outcomes; rather, it was the refusal or delay of standard treatment that accompanied it. Once treatment refusal was accounted for in the statistical model, the independent link between complementary medicine and death disappeared.¹⁰

This finding matters because it separates two things people often confuse. Using acupuncture or meditation alongside standard treatment is different from using herbal remedies instead of chemotherapy. The danger lies in the word “instead.” If an alternative approach leads you to skip or delay a surgery, a course of radiation, or a round of chemotherapy that could cure you, the consequences are not hypothetical. Breast cancer patients who replaced conventional treatment with alternative medicine had roughly four times the risk of death compared to those who received standard care, even after controlling for stage and other variables.¹

Active Surveillance Is Not the Same as Refusal

For certain low-risk cancers, doctors sometimes recommend against immediate treatment. This is called active surveillance, and it involves regular monitoring with imaging, lab tests, and sometimes biopsies to track whether the cancer changes. It is a planned, medically supervised strategy, not a refusal of care. The most common example is low-risk prostate cancer, where treatment side effects such as incontinence and sexual dysfunction can be severe, and many tumors grow so slowly that a man is more likely to die with the cancer than from it.

In a study of men with low-risk prostate cancer, about 39% preferred active surveillance over immediate treatment. Those who leaned toward surveillance tended to be older, more educated, and more aware that they had a low-risk form of the disease. They also preferred shared decision-making with their doctors and, interestingly, reported somewhat higher anxiety about their cancer than men who opted for immediate treatment.¹¹

The distinction matters because active surveillance comes with a safety net: if monitoring shows the cancer is progressing, treatment can begin promptly. Refusing treatment outright removes that safety net. If you are weighing your options and your doctor mentions active surveillance, that is a fundamentally different situation from being told you need treatment and choosing not to get it.

What Happens If You Change Your Mind

One of the most practical questions people have is whether they can come back to treatment later if they initially refuse. The answer is usually yes, but with a cost. A study of Hodgkin lymphoma patients in British Columbia tracked 15 who initially refused treatment. Of those, 13 eventually accepted it, but the average time to starting treatment was about 76 weeks, compared with roughly 5 weeks for patients who accepted up front. By the time refusers came around, many had more advanced disease. The proportion with advanced-stage cancer jumped from 20% at initial diagnosis to 62% by the time they started treatment, and most had developed higher-risk disease features.¹²

The survival consequences were real but not catastrophic in this particular cancer, which is generally quite treatable. Five-year overall survival was 93% for the refusers who eventually accepted treatment, compared with 98% for those who started on time. But progression-free survival, the time without the cancer coming back, was meaningfully worse: 65% versus 84%. And 13% of the refusers eventually died of their lymphoma, compared with 4% of the control group.¹² This was a small study of a highly curable cancer. For less treatable cancers, the window to change your mind and still achieve a good outcome may be much narrower.

Treatment plans often have to change, too. What might have been a straightforward surgery when the cancer was localized may become a more aggressive regimen involving chemotherapy and radiation once the disease has spread. In the Hodgkin lymphoma study, the majority of patients who delayed had their treatment plan altered because the cancer had progressed. Delayed treatment is still better than no treatment, but waiting typically means more intensive therapy and lower odds of a cure.

Palliative and Hospice Care

If you decide not to pursue curative treatment, or if curative treatment is no longer an option, palliative care and hospice become central to your experience. Palliative care focuses on managing symptoms and improving quality of life. It can happen alongside cancer treatment, and it does not mean giving up. Hospice care, on the other hand, typically begins when curative efforts have ended and the focus shifts entirely to comfort during the final phase of life.

Research suggests that enrolling in hospice can meaningfully change the end-of-life experience. In a study of over 200 deceased cancer patients, those who enrolled in hospice had significantly fewer emergency department visits, hospitalizations, and unplanned clinic visits after stopping treatment. The average number of these visits dropped by more than half once patients were in hospice. Among patients not in hospice, the burden of emergency healthcare was roughly twice as high.¹³ The data suggest that hospice provides timely medical interventions and continuity of care that reduce the chaos of repeated hospital visits.

If you are refusing curative treatment but not yet at end of life, palliative care can still help manage emerging symptoms like pain, nausea, or difficulty breathing. You do not have to be dying to receive palliative support. Many cancer centers now integrate palliative care early in the disease course, and it is available whether or not you are pursuing treatment for the cancer itself.

When a Parent Refuses Treatment for a Child

The ethics and the law shift dramatically when the patient is a child. Adults have the legal right to refuse their own medical treatment, even when that decision is likely to shorten their life. But parents do not have an unlimited right to refuse treatment on behalf of their children. When a child has a curable cancer and a parent declines treatment, hospitals and doctors face a genuine dilemma.

A qualitative study of pediatric oncologists found that legal involvement, typically starting with a report to child protective services, is a recognized option when families refuse treatment for children with curable cancers. Filing a CPS report was the most common first step, though doctors recognized that even raising the possibility could feel threatening or coercive to families. In some cases, families temporarily lost legal custody but kept physical custody, meaning they were expected to bring the child in for treatment or face further legal action. In other cases, children were placed in medical foster care to ensure treatment was administered.¹⁴

Not every disagreement ends in court, though. Pediatric oncologists have described strategies for resolving refusals without legal intervention: communicating directly with alternative medicine providers the family trusts, offering a time-limited trial of the family’s preferred approach before starting chemotherapy, or even praying with the family if that is meaningful to them. In one case series, these approaches led to voluntary acceptance of recommended treatment without any legal involvement.¹⁵ These are small-scale examples, not proven protocols, but they illustrate that creative, respectful engagement can sometimes break an impasse.

How Doctors Respond to Refusal

Physicians do not treat all refusals the same way. Research into the doctor-patient dynamic shows that the amount of pressure a doctor will exert to persuade you depends heavily on whether the treatment goal is curative or palliative. When a treatment could cure you, doctors tend to push harder to change your mind. When the treatment is aimed at extending life or managing symptoms rather than curing the cancer, doctors are more likely to respect your decision without significant persuasion.⁸

This sliding scale makes intuitive sense. A 35-year-old refusing surgery for early-stage colon cancer, where the cure rate is high, presents a very different situation from an 80-year-old with metastatic disease declining a chemotherapy regimen that might add a few months. Doctors weigh the stakes, the likelihood of benefit, and the burden of treatment. They will generally be honest about what they think, and they should be. But the final decision, for competent adult patients, remains yours.

If you are considering refusing treatment, most oncologists will ask you to take some time before making a final decision. They may suggest a second opinion. They will often try to understand what is driving your decision, whether that is fear of side effects, distrust, financial concerns, or a philosophical stance about quality of life. This is not them trying to manipulate you; it is them trying to make sure your decision is informed and not based on a misunderstanding about what treatment would actually involve.

The Role of Tumor Biology and Timing

One of the most underappreciated factors in this discussion is that “cancer” is not one disease. A person refusing treatment for a small, well-differentiated papillary thyroid cancer, which has a 20-year survival rate above 95% even with treatment, is in a completely different position from someone refusing treatment for pancreatic adenocarcinoma.² Some slow-growing cancers give you years to reconsider. Aggressive cancers may give you weeks.

Stage at diagnosis also matters enormously. Early-stage breast cancer patients who chose alternatives over standard treatment still had 67% five-year survival, while those with stage IV disease who did the same had 0% five-year survival, compared with 34% for the conventional treatment group.¹ The window of opportunity is widest when the cancer is caught early and shrinks as it advances. This is why oncologists are most insistent about treatment when the cancer is at a curable stage: that is precisely when refusing has the highest potential cost.

Tumor growth rates also vary within the same cancer type. Among untreated hormone-receptor-positive breast cancers, the doubling time ranged from 23 days to nearly 1,900 days, and higher-grade tumors grew significantly faster.³ If your oncologist seems especially urgent about starting treatment, it may be because the biopsy results suggest a fast-growing tumor that will not wait patiently while you deliberate. Asking about tumor grade, growth rate, and how quickly the cancer is likely to progress is a reasonable way to understand how much time you realistically have to think things over.

Practical Steps If You Are Leaning Toward Refusal

If you are seriously considering refusing treatment, a few practical steps can help protect you regardless of what you ultimately decide:

Get a second opinion: Another oncologist may present your options differently, suggest a less burdensome treatment plan, or catch something the first team missed. Second opinions are standard practice, and no good doctor will be offended.
Ask about partial treatment: You do not always have to accept or refuse the entire recommended plan. Some patients decline chemotherapy but accept surgery, or agree to radiation but not hormonal therapy. Partial treatment is better than none in most situations.
Establish palliative care early: Even if you refuse curative treatment, a palliative care team can manage pain, nausea, anxiety, and other symptoms. You do not need to wait until you are dying to get this kind of support.
Document your wishes: An advance directive and a designated healthcare proxy ensure that if you become unable to communicate, your preferences are respected. This is especially important if your family disagrees with your choice.
Stay in medical contact: Refusing treatment does not mean refusing all medical care. Regular check-ins with a doctor allow you to monitor the cancer’s progression and change course if you decide to.

The evidence is clear that refusing standard treatment for curable cancers significantly worsens survival outcomes. But the evidence is equally clear that people refuse for deeply human reasons: fear, distrust, past trauma, and values that extend beyond survival statistics. Understanding what is likely to happen if you refuse, and knowing that the door to treatment often stays open if you change your mind, puts you in a better position to make the choice that is genuinely yours.

1
Cancer Research. Abstract P4-14-03: Stage-specific survival of breast cancer patients receiving alternative medicine for treatment of cancer
2
Sultan Qaboos University Medical Journal. Long-Term Survival in Patients with Cancers: Surveillance, epidemiology and end results-based analysis
3
PubMed. The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer
4
PubMed. The symptoms of advanced cancer
5
Mayo Clinic Proceedings. Management of Oncologic Emergencies: A Review
6
Journal of Oncology Navigation & Survivorship. Demographics of Individuals Refusing Cancer Treatment and Reported Pain Compared With Those in Treatment
7
PubMed Central. Oncologic outcomes after declining lung cancer surgery: mixed methods analysis of a prospective pilot cohort
8
PubMed. The medical practice of patient autonomy and cancer treatment refusals: a patients’ and physicians’ perspective
9
PubMed Central. Refusal of Guideline-Recommended Adjuvant Therapy in Oral Squamous Cell Carcinoma Is Associated with Less Favorable Survival Outcomes
10
PubMed Central. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers
11
PubMed Central. Treatment Preferences for Active Surveillance vs. Active Treatment Among Men with Low-Risk Prostate Cancer
12
Journal of Clinical Oncology. Outcomes after initial refusal of curative treatment in patients with Hodgkin’s lymphoma in British Columbia
13
PubMed Central. Hospice in end-of-life patients with cancer: does it lead to changes in nonhospice health care utilization after stopping cancer treatment?
14
Pediatrics. Legal Involvement in Pediatric Cancer Treatment Refusal: A Qualitative Study
15
PubMed. Overcoming refusal of treatment in pediatric cancer without legal involvement: A descriptive case series from interviews with pediatric oncologists